Cemiplimab in Elderly Patients with Cutaneous Squamous Cell Carcinoma: real-word experience regarding safety and efficacy
Year: 2025
Type: article
Study design: Observational Study
Abstract: Background: Cutaneous squamous cell carcinoma (cSCC) incidence continues to rise with the increasing life expectancy of the aging population. While cemiplimab has shown promising results in the treatment of cSCC, real-world data on its use in the elderly population remain limited. Given that cSCC is more common in older individuals, understanding the treatment efficacy and safety in this group is critical.
Source: EJC Skin Cancer
Authors: M. Pereira, C. Relvas, F. Kellen, S. Cabral, P. Pereira, C. Pereira, E. Gouveia, H. Nunes, F. Vaz
Institution: Instituto Português de Oncologia Francisco Gentil
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,340
OpenAlex ID: W4409143385